NeuroPace, Inc. (NPCE) vs Tectonic Therapeutic, Inc. (TECX)

A side-by-side comparison of NeuroPace, Inc. and Tectonic Therapeutic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NPCE vs TECX

growth of $100 · dividends reinvested · last 5y
NPCE -47.0% (-11.9%/yr)TECX -81.6% (-28.8%/yr)NPCE compounded faster over this window
020406080100Start $10020222023202420252026$53$18
NPCE TECX

NPCE vs TECX: by the numbers

  • •NPCE is the larger company ($443M vs $438M market cap).
  • •Both run net losses; TECX's is the smaller (0.00% vs -19.34% net margin).

Metrics side by side

Valuation

MetricNPCETECX
P/S ratio4.49N/A
P/B ratio37.311.96

Profitability

MetricNPCETECX
Gross margin79.63%0.00%
Operating margin-15.26%0.00%
Net margin-19.34%0.00%
ROE-160.85%-38.32%
ROIC-18.95%-41.88%

Growth (annualized)

MetricNPCETECX
Revenue CAGR (5Y)15.85%N/A
Total return CAGR (5Y)-4.94%-18.45%

Frequently asked

How have NPCE and TECX total returns compared?
Over the past 5 years, NPCE delivered -4.94% and TECX delivered -18.45% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.